|Last Price||Today's Change||52-Week Range||Trading Volume|
|0.39 CAD||0.02 (+5.41%)||0.335 - 1.68||274.0 thousand (Below Avg)|
Market data as of 3:58PM 05/25/15. Quotes are delayed by at least 15 min.
Aeterna Zentaris Announces Election of Directors at 2015 Shareholders' Meeting
PR Newswire - Monday 05/11/2015 1:35 PM ET
Aeterna Zentaris Reports 1st Quarter 2015 Financial and Operating Results
PR Newswire - Thursday 05/07/2015 5:02 PM ET
Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for Saizen® (Somatropin (rDNA origin) for Injection) in the U.S.
PR Newswire - Thursday 05/07/2015 7:30 AM ET
Aeterna Zentaris to Announce First Quarter 2015 Financial and Operating Results on May 7, 2015 and Hold Annual & Special Shareholders Meeting on May 8, 2015
PR Newswire - Friday 05/01/2015 10:00 AM ET
Aeterna Zentaris: Data Safety Monitoring Board Recommends Continuation of Phase 3 Study of Zoptarelin Doxorubicin in Advanced Endometrial Cancer
PR Newswire - Monday 04/27/2015 4:15 PM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.